Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study
Open accessThe DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Abstract
In bipolar disorder the discontinuation of lithium prophylaxis is associated with early episode precipitation. Is this `rebound' phenomenon peculiar to lithium? This naturalistic retrospective case note review investigated the frequency of immediate recurrence after discontinuation of any prophylactic treatment. Bipolar patients who stopped at least one medication after at least 6 months of remission were studied. A total of 310 case notes were examined in a systematic search. A total of 53 cases of discontinuation in 48 subjects were found. Discontinued medications included lithium, valproate, carbamazepine, typical and atypical antipsychotics and antidepressants. Recurrence occurred within 3 months of medication withdrawal in 39 cases (74%). Over half of the discontinuation episodes involved lithium: recurrence occurred in 86% of these cases. In the groups stopping other prophylactic agents, a majority of subjects suffered recurrence: anticonvulsants (89%), antipsychotics (64%) and antidepressants (58%). However, these groups were small and the clarity of the data was undermined by the simultaneous withdrawal of other agents. Manic and hypomanic episodes were the most common form of recurrences. Depressive episodes occurred proportionately most frequently following antidepressant withdrawal. More than half of recurrences required hospital admission. This study provides preliminary naturalistic evidence that early episode recurrence in bipolar disorder is not peculiar to lithium withdrawal but may occur following withdrawal of medication from all classes recommended in prophylaxis. These findings, if replicated, have important implications for clinical practice and for research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Withdrawal of other mood stabilizers also predicts recurrence.348, 349”
Citations
Cites
Baastrup, P. C., Poulsen, J. C., Schou, M., Thomsen, K., & Amdisen, A. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92870-9 · Cited by 505 · cited 2×
“The precipitation of both manic and depressive recurrences is reported on its withdrawal (Baastrup et al., 1970; Melia et al., 1970; Mander, 1986; Mander and Loudon, 1988; Suppes et al., 1991).”
BackgroundRisk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392 · cited 2×
“The precipitation of both manic and depressive recurrences is reported on its withdrawal (Baastrup et al., 1970; Melia et al., 1970; Mander, 1986; Mander and Loudon, 1988; Suppes et al., 1991).”
BackgroundGoodwin, G. M. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002003 · Cited by 390 · cited 1×
“Lithium, anticonvulsants, antipsychotics and antidepressants may be used in the management of acute episodes and in maintenance treatment to prevent recurrence (Goodwin, 2003).”
BackgroundTohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317 · cited 2×
“Preliminary evidence for a rebound effect with olanzapine was found in the continuation phase of a study examining its efficacy in the treatment of mania (Tohen et al., 2006).”
BackgroundAltshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Goodwin, G. M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.149 · Cited by 162 · cited 1×
“Occurrence of ‘rebound mania’ may negate the benefits of lithium treatment altogether in the poorly concordant subject (Goodwin, 1994).”
BackgroundProphylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders
Melia, P. I. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.116.535.621 · Cited by 159
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications
Baldessarini, R. J., Tondo, L., & Viguera, A. C. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10106.x · Cited by 153 · cited 1×
“Dose tapering rather than abrupt discontinuation may reduce the risk of early recurrence and suicidal risk (Baldessarini et al., 1999).”
BackgroundCognitive impairment in bipolar affective disorder: implications for the bipolar diathesis
Ferrier, I. N., & Thompson, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.4.293 · Cited by 129
RAPID RECURRENCE OF MANIA FOLLOWING ABRUPT DISCONTINUATION OF LITHIUM
Mander, A. J., & Loudon, J. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92947-9 · Cited by 86 · cited 2×
“The precipitation of both manic and depressive recurrences is reported on its withdrawal (Baastrup et al., 1970; Melia et al., 1970; Mander, 1986; Mander and Loudon, 1988; Suppes et al., 1991).”
Background
Research works printed but not linked: 2
- Franks, MA, 2005, Clin Approaches Bipolar Disord, 4, 11
- Young, AH, 2001, Lancet, 1355, 1184
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
“Tapering is also preferable to sudden discontinuation for valproate (IV) (Franks et al., 2008).”
Self-citation(2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7090su1cj · Cited by 282
Oxcarbazepine for acute affective episodes in bipolar disorder
Vasudev, A., Macritchie, K., Vasudev, K., Watson, S., Geddes, J., & Young, A. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004857.pub2 · Cited by 198
Self-citationA Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157
Metadata
- Authors
- Franks, M., Macritchie, K., Mahmood, T., & Young, A.
- Affiliations
- Royal Victoria Infirmary (GB)
- Stanley Research Centre, University of Newcastle upon Tyne, Royal Victoria Infirmary, Leazes Wing, Queen Victoria Road, Newcastle upon Tyne, UK
- Leeds Mental Health Teaching NHS Trust, Malham House, Hyde Terrace, Leeds, UK
- Department of Psychiatry, University of British Columbia, Vancouver BC, Canada,
- ORCID
- Mahmood, T
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-06
- Volume
- 22
- Issue
- 4
- Pages
- 452-456
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2119976812
- Cited by
- 39
- References
- 15
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 1 · 2012: 2
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, drug discontinuation, prophylaxis, lithium withdrawal, valproic acid, carbamazepine, antipsychotic drugs, antidepressants, manic episodes, hypomanic episodes, depressive episodes, relapse after remission, antiepileptic drugs
- MeSH terms
- Anticonvulsants, Antidepressive Agents, Bipolar Disorder, Depressive Disorder, Humans, Recurrence, Retrospective Studies, Risk, Substance Withdrawal Syndrome, Antipsychotic Agents, Lithium Compounds, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study. https://app.cochat.ai/papers/10.1177/0269881107085238
- The paper
- Franks, M., Macritchie, K., Mahmood, T., & Young, A. (2008). Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881107085238
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.